Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
This report aims to provide a comprehensive presentation of the global market for Parkinson's Disease (PD) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parkinson's Disease (PD) Drugs. This report contains market size and forecasts of Parkinson's Disease (PD) Drugs in global, including the following market information:
Global Parkinson's Disease (PD) Drugs Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global Parkinson's Disease (PD) Drugs Market Sales, 2018-2023, 2024-2035, (K Pcs)
Global top five Parkinson's Disease (PD) Drugs companies in 2022 (%)
The global Parkinson's Disease (PD) Drugs market was valued at US$ 5651 million in 2022 and is projected to reach US$ 7494.1 million by 2035, at a CAGR of 4.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Parkinson Disease Drug key players include Merck, Akorn, GSK, Boehringer Ingelheim, Teva Pharmaceutical, etc.
We surveyed the Parkinson's Disease (PD) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Parkinson's Disease (PD) Drugs Market, by Type, 2018-2023, 2024-2035 ($ Millions) & (K Pcs)
Global Parkinson's Disease (PD) Drugs Market Segment Percentages, by Type, 2022 (%)
Dopamine Agonist
Monoamine Oxidase Inhibitors
Acetylcholinesterase Inhibitors
Glutamate Inhibitors
Global Parkinson's Disease (PD) Drugs Market, by Application, 2018-2023, 2024-2035 ($ Millions) & (K Pcs)
Global Parkinson's Disease (PD) Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Family
Global Parkinson's Disease (PD) Drugs Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions) & (K Pcs)
Global Parkinson's Disease (PD) Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Parkinson's Disease (PD) Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Parkinson's Disease (PD) Drugs revenues share in global market, 2022 (%)
Key companies Parkinson's Disease (PD) Drugs sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Parkinson's Disease (PD) Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical Industries
AbbVie
Abital Pharma
Addex Therapeutics
Biogen
Eisai
Eli Lilly
F. Hoffmann-La Roche
H. Lundbeck
Impax Laboratories
Kyowa Hakko Kirin
Otsuka Pharmaceutical
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Parkinson's Disease (PD) Drugs, market overview.
Chapter 2: Global Parkinson's Disease (PD) Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Parkinson's Disease (PD) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Parkinson's Disease (PD) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Parkinson's Disease (PD) Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Parkinson's Disease (PD) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Parkinson's Disease (PD) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Parkinson's Disease (PD) Drugs Overall Market Size
2.1 Global Parkinson's Disease (PD) Drugs Market Size: 2022 VS 2035
2.2 Global Parkinson's Disease (PD) Drugs Revenue, Prospects & Forecasts: 2018-2035
2.3 Global Parkinson's Disease (PD) Drugs Sales: 2018-2035
3 Company Landscape
3.1 Top Parkinson's Disease (PD) Drugs Players in Global Market
3.2 Top Global Parkinson's Disease (PD) Drugs Companies Ranked by Revenue
3.3 Global Parkinson's Disease (PD) Drugs Revenue by Companies
3.4 Global Parkinson's Disease (PD) Drugs Sales by Companies
3.5 Global Parkinson's Disease (PD) Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Parkinson's Disease (PD) Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Parkinson's Disease (PD) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Parkinson's Disease (PD) Drugs Players in Global Market
3.8.1 List of Global Tier 1 Parkinson's Disease (PD) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Parkinson's Disease (PD) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Parkinson's Disease (PD) Drugs Market Size Markets, 2022 & 2035
4.1.2 Dopamine Agonist
4.1.3 Monoamine Oxidase Inhibitors
4.1.4 Acetylcholinesterase Inhibitors
4.1.5 Glutamate Inhibitors
4.2 By Type - Global Parkinson's Disease (PD) Drugs Revenue & Forecasts
4.2.1 By Type - Global Parkinson's Disease (PD) Drugs Revenue, 2018-2023
4.2.2 By Type - Global Parkinson's Disease (PD) Drugs Revenue, 2024-2035
4.2.3 By Type - Global Parkinson's Disease (PD) Drugs Revenue Market Share, 2018-2035
4.3 By Type - Global Parkinson's Disease (PD) Drugs Sales & Forecasts
4.3.1 By Type - Global Parkinson's Disease (PD) Drugs Sales, 2018-2023
4.3.2 By Type - Global Parkinson's Disease (PD) Drugs Sales, 2024-2035
4.3.3 By Type - Global Parkinson's Disease (PD) Drugs Sales Market Share, 2018-2035
4.4 By Type - Global Parkinson's Disease (PD) Drugs Price (Manufacturers Selling Prices), 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Parkinson's Disease (PD) Drugs Market Size, 2022 & 2035
5.1.2 Hospital
5.1.3 Family
5.2 By Application - Global Parkinson's Disease (PD) Drugs Revenue & Forecasts
5.2.1 By Application - Global Parkinson's Disease (PD) Drugs Revenue, 2018-2023
5.2.2 By Application - Global Parkinson's Disease (PD) Drugs Revenue, 2024-2035
5.2.3 By Application - Global Parkinson's Disease (PD) Drugs Revenue Market Share, 2018-2035
5.3 By Application - Global Parkinson's Disease (PD) Drugs Sales & Forecasts
5.3.1 By Application - Global Parkinson's Disease (PD) Drugs Sales, 2018-2023
5.3.2 By Application - Global Parkinson's Disease (PD) Drugs Sales, 2024-2035
5.3.3 By Application - Global Parkinson's Disease (PD) Drugs Sales Market Share, 2018-2035
5.4 By Application - Global Parkinson's Disease (PD) Drugs Price (Manufacturers Selling Prices), 2018-2035
6 Sights by Region
6.1 By Region - Global Parkinson's Disease (PD) Drugs Market Size, 2022 & 2035
6.2 By Region - Global Parkinson's Disease (PD) Drugs Revenue & Forecasts
6.2.1 By Region - Global Parkinson's Disease (PD) Drugs Revenue, 2018-2023
6.2.2 By Region - Global Parkinson's Disease (PD) Drugs Revenue, 2024-2035
6.2.3 By Region - Global Parkinson's Disease (PD) Drugs Revenue Market Share, 2018-2035
6.3 By Region - Global Parkinson's Disease (PD) Drugs Sales & Forecasts
6.3.1 By Region - Global Parkinson's Disease (PD) Drugs Sales, 2018-2023
6.3.2 By Region - Global Parkinson's Disease (PD) Drugs Sales, 2024-2035
6.3.3 By Region - Global Parkinson's Disease (PD) Drugs Sales Market Share, 2018-2035
6.4 North America
6.4.1 By Country - North America Parkinson's Disease (PD) Drugs Revenue, 2018-2035
6.4.2 By Country - North America Parkinson's Disease (PD) Drugs Sales, 2018-2035
6.4.3 US Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.4.4 Canada Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.4.5 Mexico Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.5 Europe
6.5.1 By Country - Europe Parkinson's Disease (PD) Drugs Revenue, 2018-2035
6.5.2 By Country - Europe Parkinson's Disease (PD) Drugs Sales, 2018-2035
6.5.3 Germany Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.5.4 France Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.5.5 U.K. Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.5.6 Italy Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.5.7 Russia Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.5.8 Nordic Countries Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.5.9 Benelux Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.6 Asia
6.6.1 By Region - Asia Parkinson's Disease (PD) Drugs Revenue, 2018-2035
6.6.2 By Region - Asia Parkinson's Disease (PD) Drugs Sales, 2018-2035
6.6.3 China Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.6.4 Japan Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.6.5 South Korea Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.6.6 Southeast Asia Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.6.7 India Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.7 South America
6.7.1 By Country - South America Parkinson's Disease (PD) Drugs Revenue, 2018-2035
6.7.2 By Country - South America Parkinson's Disease (PD) Drugs Sales, 2018-2035
6.7.3 Brazil Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.7.4 Argentina Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Parkinson's Disease (PD) Drugs Revenue, 2018-2035
6.8.2 By Country - Middle East & Africa Parkinson's Disease (PD) Drugs Sales, 2018-2035
6.8.3 Turkey Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.8.4 Israel Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.8.5 Saudi Arabia Parkinson's Disease (PD) Drugs Market Size, 2018-2035
6.8.6 UAE Parkinson's Disease (PD) Drugs Market Size, 2018-2035
7 Manufacturers & Brands Profiles
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Company Summary
7.1.2 Boehringer Ingelheim Business Overview
7.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Major Product Offerings
7.1.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Boehringer Ingelheim Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2018-2023)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Parkinson's Disease (PD) Drugs Major Product Offerings
7.3.4 Novartis Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Teva Pharmaceutical Industries
7.4.1 Teva Pharmaceutical Industries Company Summary
7.4.2 Teva Pharmaceutical Industries Business Overview
7.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Major Product Offerings
7.4.4 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.5 AbbVie
7.5.1 AbbVie Company Summary
7.5.2 AbbVie Business Overview
7.5.3 AbbVie Parkinson's Disease (PD) Drugs Major Product Offerings
7.5.4 AbbVie Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2018-2023)
7.5.5 AbbVie Key News & Latest Developments
7.6 Abital Pharma
7.6.1 Abital Pharma Company Summary
7.6.2 Abital Pharma Business Overview
7.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Major Product Offerings
7.6.4 Abital Pharma Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Abital Pharma Key News & Latest Developments
7.7 Addex Therapeutics
7.7.1 Addex Therapeutics Company Summary
7.7.2 Addex Therapeutics Business Overview
7.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Major Product Offerings
7.7.4 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Addex Therapeutics Key News & Latest Developments
7.8 Biogen
7.8.1 Biogen Company Summary
7.8.2 Biogen Business Overview
7.8.3 Biogen Parkinson's Disease (PD) Drugs Major Product Offerings
7.8.4 Biogen Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Biogen Key News & Latest Developments
7.9 Eisai
7.9.1 Eisai Company Summary
7.9.2 Eisai Business Overview
7.9.3 Eisai Parkinson's Disease (PD) Drugs Major Product Offerings
7.9.4 Eisai Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Eisai Key News & Latest Developments
7.10 Eli Lilly
7.10.1 Eli Lilly Company Summary
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Major Product Offerings
7.10.4 Eli Lilly Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Eli Lilly Key News & Latest Developments
7.11 F. Hoffmann-La Roche
7.11.1 F. Hoffmann-La Roche Company Summary
7.11.2 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Business Overview
7.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Major Product Offerings
7.11.4 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2018-2023)
7.11.5 F. Hoffmann-La Roche Key News & Latest Developments
7.12 H. Lundbeck
7.12.1 H. Lundbeck Company Summary
7.12.2 H. Lundbeck Parkinson's Disease (PD) Drugs Business Overview
7.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Major Product Offerings
7.12.4 H. Lundbeck Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2018-2023)
7.12.5 H. Lundbeck Key News & Latest Developments
7.13 Impax Laboratories
7.13.1 Impax Laboratories Company Summary
7.13.2 Impax Laboratories Parkinson's Disease (PD) Drugs Business Overview
7.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Major Product Offerings
7.13.4 Impax Laboratories Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Impax Laboratories Key News & Latest Developments
7.14 Kyowa Hakko Kirin
7.14.1 Kyowa Hakko Kirin Company Summary
7.14.2 Kyowa Hakko Kirin Business Overview
7.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Major Product Offerings
7.14.4 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Kyowa Hakko Kirin Key News & Latest Developments
7.15 Otsuka Pharmaceutical
7.15.1 Otsuka Pharmaceutical Company Summary
7.15.2 Otsuka Pharmaceutical Business Overview
7.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Major Product Offerings
7.15.4 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Otsuka Pharmaceutical Key News & Latest Developments
7.16 Pfizer
7.16.1 Pfizer Company Summary
7.16.2 Pfizer Business Overview
7.16.3 Pfizer Parkinson's Disease (PD) Drugs Major Product Offerings
7.16.4 Pfizer Parkinson's Disease (PD) Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Pfizer Key News & Latest Developments
8 Global Parkinson's Disease (PD) Drugs Production Capacity, Analysis
8.1 Global Parkinson's Disease (PD) Drugs Production Capacity, 2018-2035
8.2 Parkinson's Disease (PD) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Parkinson's Disease (PD) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Parkinson's Disease (PD) Drugs Supply Chain Analysis
10.1 Parkinson's Disease (PD) Drugs Industry Value Chain
10.2 Parkinson's Disease (PD) Drugs Upstream Market
10.3 Parkinson's Disease (PD) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Parkinson's Disease (PD) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Parkinson's Disease (PD) Drugs in Global Market
Table 2. Top Parkinson's Disease (PD) Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Parkinson's Disease (PD) Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Parkinson's Disease (PD) Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Parkinson's Disease (PD) Drugs Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Parkinson's Disease (PD) Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Parkinson's Disease (PD) Drugs Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Parkinson's Disease (PD) Drugs Product Type
Table 9. List of Global Tier 1 Parkinson's Disease (PD) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Parkinson's Disease (PD) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Global Parkinson's Disease (PD) Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Parkinson's Disease (PD) Drugs Revenue (US$, Mn), 2024-2035
Table 14. By Type - Global Parkinson's Disease (PD) Drugs Sales (K Pcs), 2018-2023
Table 15. By Type - Global Parkinson's Disease (PD) Drugs Sales (K Pcs), 2024-2035
Table 16. By Application ? Global Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2022 & 2035
Table 17. By Application - Global Parkinson's Disease (PD) Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Parkinson's Disease (PD) Drugs Revenue (US$, Mn), 2024-2035
Table 19. By Application - Global Parkinson's Disease (PD) Drugs Sales (K Pcs), 2018-2023
Table 20. By Application - Global Parkinson's Disease (PD) Drugs Sales (K Pcs), 2024-2035
Table 21. By Region ? Global Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2022 VS 2035
Table 22. By Region - Global Parkinson's Disease (PD) Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Parkinson's Disease (PD) Drugs Revenue (US$, Mn), 2024-2035
Table 24. By Region - Global Parkinson's Disease (PD) Drugs Sales (K Pcs), 2018-2023
Table 25. By Region - Global Parkinson's Disease (PD) Drugs Sales (K Pcs), 2024-2035
Table 26. By Country - North America Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2024-2035
Table 28. By Country - North America Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2024-2035
Table 30. By Country - Europe Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2024-2035
Table 32. By Country - Europe Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2024-2035
Table 34. By Region - Asia Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2024-2035
Table 36. By Region - Asia Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2024-2035
Table 38. By Country - South America Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2024-2035
Table 40. By Country - South America Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2024-2035
Table 42. By Country - Middle East & Africa Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2024-2035
Table 44. By Country - Middle East & Africa Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Parkinson's Disease (PD) Drugs Sales, (K Pcs), 2024-2035
Table 46. Boehringer Ingelheim Company Summary
Table 47. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Offerings
Table 48. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Boehringer Ingelheim Key News & Latest Developments
Table 50. GlaxoSmithKline Company Summary
Table 51. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Offerings
Table 52. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. GlaxoSmithKline Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Parkinson's Disease (PD) Drugs Product Offerings
Table 56. Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. Teva Pharmaceutical Industries Company Summary
Table 59. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Offerings
Table 60. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Teva Pharmaceutical Industries Key News & Latest Developments
Table 62. AbbVie Company Summary
Table 63. AbbVie Parkinson's Disease (PD) Drugs Product Offerings
Table 64. AbbVie Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. AbbVie Key News & Latest Developments
Table 66. Abital Pharma Company Summary
Table 67. Abital Pharma Parkinson's Disease (PD) Drugs Product Offerings
Table 68. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Abital Pharma Key News & Latest Developments
Table 70. Addex Therapeutics Company Summary
Table 71. Addex Therapeutics Parkinson's Disease (PD) Drugs Product Offerings
Table 72. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Addex Therapeutics Key News & Latest Developments
Table 74. Biogen Company Summary
Table 75. Biogen Parkinson's Disease (PD) Drugs Product Offerings
Table 76. Biogen Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Biogen Key News & Latest Developments
Table 78. Eisai Company Summary
Table 79. Eisai Parkinson's Disease (PD) Drugs Product Offerings
Table 80. Eisai Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Eisai Key News & Latest Developments
Table 82. Eli Lilly Company Summary
Table 83. Eli Lilly Parkinson's Disease (PD) Drugs Product Offerings
Table 84. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Eli Lilly Key News & Latest Developments
Table 86. F. Hoffmann-La Roche Company Summary
Table 87. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Offerings
Table 88. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. F. Hoffmann-La Roche Key News & Latest Developments
Table 90. H. Lundbeck Company Summary
Table 91. H. Lundbeck Parkinson's Disease (PD) Drugs Product Offerings
Table 92. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 93. H. Lundbeck Key News & Latest Developments
Table 94. Impax Laboratories Company Summary
Table 95. Impax Laboratories Parkinson's Disease (PD) Drugs Product Offerings
Table 96. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 97. Impax Laboratories Key News & Latest Developments
Table 98. Kyowa Hakko Kirin Company Summary
Table 99. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Offerings
Table 100. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 101. Kyowa Hakko Kirin Key News & Latest Developments
Table 102. Otsuka Pharmaceutical Company Summary
Table 103. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Offerings
Table 104. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 105. Otsuka Pharmaceutical Key News & Latest Developments
Table 106. Pfizer Company Summary
Table 107. Pfizer Parkinson's Disease (PD) Drugs Product Offerings
Table 108. Pfizer Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 109. Pfizer Key News & Latest Developments
Table 110. Parkinson's Disease (PD) Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 111. Global Parkinson's Disease (PD) Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 112. Global Parkinson's Disease (PD) Drugs Production by Region, 2018-2023 (K Pcs)
Table 113. Global Parkinson's Disease (PD) Drugs Production by Region, 2024-2035 (K Pcs)
Table 114. Parkinson's Disease (PD) Drugs Market Opportunities & Trends in Global Market
Table 115. Parkinson's Disease (PD) Drugs Market Drivers in Global Market
Table 116. Parkinson's Disease (PD) Drugs Market Restraints in Global Market
Table 117. Parkinson's Disease (PD) Drugs Raw Materials
Table 118. Parkinson's Disease (PD) Drugs Raw Materials Suppliers in Global Market
Table 119. Typical Parkinson's Disease (PD) Drugs Downstream
Table 120. Parkinson's Disease (PD) Drugs Downstream Clients in Global Market
Table 121. Parkinson's Disease (PD) Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Parkinson's Disease (PD) Drugs Segment by Type in 2022
Figure 2. Parkinson's Disease (PD) Drugs Segment by Application in 2022
Figure 3. Global Parkinson's Disease (PD) Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Parkinson's Disease (PD) Drugs Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Parkinson's Disease (PD) Drugs Revenue, 2018-2035 (US$, Mn)
Figure 7. Parkinson's Disease (PD) Drugs Sales in Global Market: 2018-2035 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Parkinson's Disease (PD) Drugs Revenue in 2022
Figure 9. By Type - Global Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2022 & 2035
Figure 10. By Type - Global Parkinson's Disease (PD) Drugs Revenue Market Share, 2018-2035
Figure 11. By Type - Global Parkinson's Disease (PD) Drugs Sales Market Share, 2018-2035
Figure 12. By Type - Global Parkinson's Disease (PD) Drugs Price (USD/Pcs), 2018-2035
Figure 13. By Application - Global Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2022 & 2035
Figure 14. By Application - Global Parkinson's Disease (PD) Drugs Revenue Market Share, 2018-2035
Figure 15. By Application - Global Parkinson's Disease (PD) Drugs Sales Market Share, 2018-2035
Figure 16. By Application - Global Parkinson's Disease (PD) Drugs Price (USD/Pcs), 2018-2035
Figure 17. By Region - Global Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2022 & 2035
Figure 18. By Region - Global Parkinson's Disease (PD) Drugs Revenue Market Share, 2018 VS 2022 VS 2035
Figure 19. By Region - Global Parkinson's Disease (PD) Drugs Revenue Market Share, 2018-2035
Figure 20. By Region - Global Parkinson's Disease (PD) Drugs Sales Market Share, 2018-2035
Figure 21. By Country - North America Parkinson's Disease (PD) Drugs Revenue Market Share, 2018-2035
Figure 22. By Country - North America Parkinson's Disease (PD) Drugs Sales Market Share, 2018-2035
Figure 23. US Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 24. Canada Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 25. Mexico Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 26. By Country - Europe Parkinson's Disease (PD) Drugs Revenue Market Share, 2018-2035
Figure 27. By Country - Europe Parkinson's Disease (PD) Drugs Sales Market Share, 2018-2035
Figure 28. Germany Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 29. France Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 30. U.K. Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 31. Italy Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 32. Russia Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 33. Nordic Countries Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 34. Benelux Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 35. By Region - Asia Parkinson's Disease (PD) Drugs Revenue Market Share, 2018-2035
Figure 36. By Region - Asia Parkinson's Disease (PD) Drugs Sales Market Share, 2018-2035
Figure 37. China Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 38. Japan Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 39. South Korea Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 40. Southeast Asia Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 41. India Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 42. By Country - South America Parkinson's Disease (PD) Drugs Revenue Market Share, 2018-2035
Figure 43. By Country - South America Parkinson's Disease (PD) Drugs Sales Market Share, 2018-2035
Figure 44. Brazil Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 45. Argentina Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 46. By Country - Middle East & Africa Parkinson's Disease (PD) Drugs Revenue Market Share, 2018-2035
Figure 47. By Country - Middle East & Africa Parkinson's Disease (PD) Drugs Sales Market Share, 2018-2035
Figure 48. Turkey Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 49. Israel Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 50. Saudi Arabia Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 51. UAE Parkinson's Disease (PD) Drugs Revenue, (US$, Mn), 2018-2035
Figure 52. Global Parkinson's Disease (PD) Drugs Production Capacity (K Pcs), 2018-2035
Figure 53. The Percentage of Production Parkinson's Disease (PD) Drugs by Region, 2022 VS 2035
Figure 54. Parkinson's Disease (PD) Drugs Industry Value Chain
Figure 55. Marketing Channels
